Lever
Lifestyle
- Regular moderate exercise
- Stress management techniques
- Adequate sleep
Blutwerte · Marker
CD4/CD8-Ratio
T-Cell Ratio · T-Helfer/Suppressor-Ratio · CD4:CD8
ImmunsystemZeitabhängig
- Einheit:
- ratio
- Abbreviation
- CD4/CD8
The CD4/CD8 ratio quantifies the balance between CD4+ helper T cells and CD8+ cytotoxic T cells in the blood.
Reference Ranges
Reference
1–3.5ratio
1
1.5
2.5
3.5
LowNormalHigh
Reference
Optimal
Unit · ratioReference ranges can vary based on laboratory standards and population demographics.
Overview
Übersicht
The CD4/CD8 ratio, also known as the T-cell ratio, measures the relative proportions of CD4+ helper T cells to CD8+ cytotoxic T cells in the blood. This biomarker provides insight into the immune system's balance and functionality. Clinically, the CD4/CD8 ratio is significant in assessing immune competence and is often used in the context of HIV/AIDS to monitor disease progression and treatment efficacy. A low CD4/CD8 ratio is indicative of immune suppression, often seen in HIV infection, while an elevated ratio may suggest autoimmune conditions or certain malignancies. In the realm of athletic performance and biohacking, maintaining a balanced CD4/CD8 ratio is considered important for optimal immune function and recovery. Athletes may monitor this ratio to ensure their immune system is not compromised by intense training. However, researchers have noted that various factors, such as infections, stress, and even time of day, can influence the CD4/CD8 ratio, necessitating careful interpretation of results. It is important to consider these confounders when evaluating the CD4/CD8 ratio to avoid misinterpretation of immune status.
Klinische Bedeutung
A low CD4/CD8 ratio is typically associated with immune suppression, as seen in HIV/AIDS. An elevated ratio may indicate autoimmune disorders or certain types of cancer.
Dynamics
Trend Interpretation
Rising Values
Progressively rising values may indicate an improvement in immune function or a shift towards autoimmunity. Retest in 3-6 months.
Falling Values
Progressively falling values suggest potential immune suppression or worsening of conditions like HIV.
Re-test Interval
4 weeks if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Autoimmune disorders
- Chronic infections
- Certain cancers
- Allergic reactions
- Chronic stress
Cause
Low Levels
- HIV/AIDS
- Immunosuppressive therapy
- Acute viral infections
- Chronic stress
- Malnutrition
Protocol
How to Optimize
Lever
Nutrition
- Balanced diet rich in fruits and vegetables
- Adequate protein intake
Lever
Supplementation
- Vitamin D
- Omega-3 fatty acids
Note:
Consult a healthcare provider for personalized advice, especially if considering changes to medication or supplements.
Testing Guidelines
✓Fasting Not Required
🕐Time-Sensitive
CD4/CD8 ratio may vary throughout the day; consistent timing is recommended for serial testing.
Testing Frequency
Annually for general health monitoring, more frequently if managing a condition like HIV.
Interfering Factors
- Recent infections
- Acute stress
- Vaccinations
Open Research Questions
Current research suggests that the optimal cutoff values for the CD4/CD8 ratio as a predictive biomarker remain debated, particularly in different cancer types and treatment regimens. Researchers have not yet established standardized reference ranges or fully understood confounding factors such as the impact of concurrent therapies on T-cell populations. Additionally, clinical questions remain unanswered regarding the long-term prognostic value of the CD4/CD8 ratio in various malignancies and its role in guiding immunotherapy strategies.
38 Research Publications
532
Total Citations
23
Human/RCT
2.3
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
HumanInfluence3.0
120
Researchers investigated the role of granulocytic myeloid-derived suppressor cells (G-MDSCs) in multiple myeloma and identified a significant association between mature neutrophil/T-cell ratios and patient outcomes. The study revealed that a higher ratio correlated with inferior progression-free survival. Additionally, the study established optimal markers for monitoring G-MDSCs, enhancing the understanding of their immunosuppressive potential.
02Top
#02
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study.
HumanInfluence5.0
89
03Top
#03
Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
HumanInfluence3.0
57
This study focused on differentiating erythrodermic cutaneous T-cell lymphoma from atopic dermatitis. Researchers found that a high CD4/CD8 ratio in lesional skin was helpful in diagnosing erythrodermic cutaneous T-cell lymphoma, indicating its potential as a diagnostic marker.
04
#04
Hyper-IgE syndromes: reviewing PGM3 deficiency.
ReviewInfluence3.0
42
Researchers reviewed hyper-IgE syndromes and found that mutations in PGM3 lead to a reversed CD4/CD8 ratio and T-cell proliferation defects. The study highlights the implications of glycosylation defects on immune function and the need for further research into these syndromes.
05
#05
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
HumanInfluence4.0
24
This study examined the relationship between CD4/CD8 ratios and cancer risk in people with HIV. Researchers found that a low CD4/CD8 ratio was associated with an increased risk of various cancers, suggesting its potential as a clinical biomarker.
06
#06
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood.
Human
22
07
#07
Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Human
22
Researchers analyzed the prognostic role of peripheral blood T-cell subsets in triple-negative breast cancer (TNBC). They found that a higher CD4+/CD8+ ratio was associated with better treatment efficacy and longer progression-free and overall survival.
08
#08
Inflammatory mediators and lung abnormalities in HIV: A systematic review.
ReviewInfluence1.0
21
Researchers conducted a systematic review to assess the impact of inflammatory markers on lung function in individuals with HIV and pneumonia. They found that the CD4/CD8 ratio was associated with lung abnormalities, indicating its potential role as a biomarker in this population.
09
#09
Immunological Biomarkers of COVID-19.
Lei Rongwei & Mohan Chandra · Critical reviews in immunology · 2020
ReviewInfluence1.0
19
Researchers reviewed various hematological and inflammatory biomarkers associated with COVID-19 severity. They highlighted significant changes in lymphocyte counts and ratios, which can aid in diagnosing disease severity. The study emphasizes the importance of multiplex biomarker analyses for better clinical outcomes.
Key findings
- 01Researchers observed significant changes in blood cell counts, such as lymphocytes and neutrophils, in COVID-19 patients.
- 02They identified key inflammatory markers, including interleukins and other proteins, that correlate with disease severity.
- 03The study highlighted that using a combination of biomarkers provides better diagnostic insights than relying on single markers alone.
10
#10
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.
HumanInfluence1.0
16
Researchers found that the abundance of mature dendritic cells in metastatic melanoma correlates with immune response and progression-free survival when combined with the CD8 T cell ratio. This study highlights the potential of dendritic cell abundance as a predictive biomarker for immunotherapy.
Clinical Trials (3)
3
Total Trials
931
Total Enrolled
Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual)
Sponsor
Hospitales Universitarios Virgen del Rocío
Enrollment
153
Started
2017
Primary outcome
CD4/CD8 ratio
HIV Infections
Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Enrollment
721
Started
2014
Primary outcome
Change From Baseline in CD4/CD8 ratio
HIV/AIDS
Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
NCT01904201TERMINATED
Sponsor
QIAGEN Gaithersburg, Inc
Enrollment
57
Started
2013
Primary outcome
Correlation between QFM and CD4 counts and CD4/CD8 ratios
HIV Positive
Publication Trend
Research publications about CD4/CD8-Ratio over time
9totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer